Compare ARK Genomic Revolution ETF (ARKG) vs Ecolab Inc. (ECL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Ecolab Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.96, while Ecolab Inc. trades at $274.33 (market cap $77.20B). The key difference: Ecolab Inc. pays a 1.06% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Ecolab Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | ECL | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $308.35 |
52-Week Low | $23.09 | $245.73 |
Market Cap | — | $77.20B |
Enterprise Value | — | $85.95B |
Dividend Yield | — | 1.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ECL trades at $274.31, up 0.47% on the day, with a bullish technical signal and strong analyst support. The company reported $16.08B in 2025 revenue, $2.08B net income, and maintains robust profitability with a 12.8% net margin and 22.31% ROE. Recent news highlights the $4.75B CoolIT acquisition, expanding its AI cooling portfolio, and a consistent dividend payout.
Outlook remains positive with a consensus price target of $327.43, implying 19% upside, though risks include rising costs and negative cash flow trends. Earnings growth and digital expansion are key catalysts, but investors should monitor execution on acquisitions and margin pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
